Eric A. Smith, MD, PhD

Research Instructor, University of Utah School of Medicine, Department of Pathology

Specialties

• Anatomic pathology
• Molecular genetic pathology

Education

• Medical Degree—University of Cincinnati
• Doctorate Degree—University of Cincinnati
• AP/CP Physician Scientist Track Residency—University of Utah and ARUP Laboratories
• Fellow—Molecular Genetic Pathology, University of Utah and ARUP Laboratories

Certification/Affiliations

• Anatomic and Clinical Pathology Board Certification
• Molecular Genetic Pathology, Board Eligible 2025

Research Interests

• Rare melanoma subtypes
• Rare sarcomas and ENT tumors
• DNA repair
• Complex chromosomal abnormalities
• Diagnostic and prognostic biomarker identification

Awards

• William L. Roberts Memorial Fund, 2024-2025
• Research Grand Rounds, Second Place Pathology Fellow Presenter Award, University of Utah, 2025
• Research Grand Rounds, Second Place Pathology Resident Presenter Award, University of Utah, 2024
• Research Grand Rounds, First Place Pathology Resident Presenter Award, University of Utah, 2022

Recent Publications

• Smith EA, Belote RL, Cruz NM, et al. Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. J Exp Clin Cancer Res. 2024;43(1):317.
• Chhibber T, Scherzer MT, Prokofyeva A, et al. Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi. J Control Release. 2025;381:113586.
• Smith EA, Parker R, Genesi B, et al. Have you caught that outlier yet? Evaluate the utility of repeat testing in nutritional and toxic element assessment. Clin Chim Acta. 2022;528:84-89.
• Deacon DC, Smith EA, Judson-Torres RL. Molecular biomarkers for melanoma screening, diagnosis and prognosis: current state and future prospects. Front Med (Lausanne). 2021;8:642380.
• Grossman D, Okwundu N, Bartlett EK, et al. Prognostic gene expression profiling in cutaneous melanoma: identifying the knowledge gaps and assessing the clinical benefit. JAMA Dermatol. 2020;156(9):1004-1011.
• Oltvai ZN, Smith EA, Wiens K, et al. Neonatal respiratory failure due to novel compound heterozygous mutations in the ABCA3 lipid transporter. Cold Spring Harb Mol Case Stud. 2020;6(3):a005074.